Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Egg

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patientsC Gneiss, P Tripp, F Reichartseder, et al.
British Journal of Cancer|November 22, 2012
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104S Boeck, A Jung, R P Laubender, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patientsC Gneiss, P Tripp, F Reichartseder, et al.
British Journal of Cancer|November 22, 2012
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104S Boeck, A Jung, R P Laubender, et al.
Pageof 2